Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
You are receiving treatment concurrently with class I antiarrhythmic agents (quinine, flecainide, disopyramide, or procainamide)
Analytical Testing Every batch undergoes comprehensive HPLC peptide analysis, LC-MS identity verification, and laboratory quality control procedures to support reproducible scientific research and batch-to-batch consistency
After subcutaneous injection, peak plasma concentrations are reached within 5-20 minutes, with an elimination half-life of approximately 10-20 minutes
Blood cell production typically begins improving within 35 days, haemoglobin rises over 12 months, whilst neurological recovery may take several months
Maintenance Therapy: Once the big dose is done, smaller doses are given every 1-3 months
It also allows for incredible flexibility in dosing
US$ 29.56
US$ 21.80
US$ 21.10
